Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Ace Alzheimer Center Barcelona is a prominent non-profit foundation dedicated to the diagnosis, treatment, and research of Alzheimer's disease and other neurodegenerative disorders. Founded in 1995, the center integrates a specialized Diagnostic Unit and a Day Care Center with a high-capacity Research Department. It is globally recognized for its leadership in clinical trials, having participated in more than 140 international studies for novel Alzheimer's therapies. The foundation also spearheads major genomic research initiatives, such as the GR@ACE project, which aims to identify genetic markers for dementia. By combining clinical excellence with cutting-edge research, Ace Alzheimer Center Barcelona provides comprehensive care to thousands of patients while advancing the global understanding of neurodegeneration.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Fundació ACE Institut Català de Neurociències Aplicades.